|
|
2320 Scientific Park Drive Wilmington, NC 28405 USA phone:1.800.575.4224 fax:1.910.815.2300
|
|
| Symbol |
private |
| Founded |
0 |
| Employees |
|
|
|
| www.aaipharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Well-known branded medicines in pain management, gastroenterology and critical care. |
 |
| Management |
| Jay Lifton, Chairman of AAIPharma Inc. and Managing Director of JPMorgan Securities Inc.; Christopher Kearns, Co-Founder of Capstone Advisory Group, LLC; Stuart Markowitz, M.D., Member of the Board of Directors for MBNA Bank; Rebecca Pacholder, Investment Analyst for Sandell Asset Management Corp.; Ludo Reynders, Ph.D., Chief Executive Officer and President of AAIPharma Inc.; Ian Wallace, Managing Member of River Run Management, LLC. |
| |
|
|
| |
|
| Keywords |
| pain management, gastroenterology, critical care, PainManagement |
|
|
|
| Description |
|
AaiPharma Inc. is a science-based specialty pharmaceutical company with more than 23 years of drug development expertise. The company is focused on acquiring, improving and marketing well known branded medicines in pain management, gastroenterology and critical care. In addition to its branded product portfolio and robust pipeline, aaiPharma continues to offer comprehensive drug development services to the pharmaceutical, biotechnology, generic and device industries through its services division, AAI Development Services, with locations in North America, Europe, and Asia providing fee for service, project management and consulting solutions in analytical, bioanalytical, pharmaceutics, clinical trial and regulatory affairs services. |
 |
 |
|
|
|
|
|
|